Shattuck Labs, Inc. STTK Other Research And Development — R&D
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Shattuck Labs, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Shattuck Labs, Inc.'s other research and development — r&d.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Shattuck Labs, Inc.'s other research and development — R&D?
- Shattuck Labs, Inc. (STTK) reported other research and development — R&D of $4.67M in Q1 2026.
- How has Shattuck Labs, Inc.'s other research and development — R&D changed year-over-year?
- Shattuck Labs, Inc.'s other research and development — R&D increased by 1.3% year-over-year, from $4.61M to $4.67M.
- What is the long-term trend for Shattuck Labs, Inc.'s other research and development — R&D?
- Over 2 years (2023 to 2025), Shattuck Labs, Inc.'s other research and development — R&D has grown at a -27.3% compound annual growth rate (CAGR), from $22.34M to $11.8M.
- What does other research and development — R&D mean?
- This metric represents the total research and development expenditures specifically allocated to the 'Other' segment, which encompasses pipeline compounds and exploratory research activities outside of primary clinical programs. It reflects the company's investment in early-stage drug discovery and the maintenance of research infrastructure. Monitoring this figure helps investors assess the company's commitment to long-term pipeline diversification and innovation.